CIRRHOTIC CARDIOMYOPATHY
Clinical trials for CIRRHOTIC CARDIOMYOPATHY explained in plain language.
Never miss a new study
Get alerted when new CIRRHOTIC CARDIOMYOPATHY trials appear
Sign up with your email to follow new studies for CIRRHOTIC CARDIOMYOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a diabetes drug help people with cirrhosis avoid deadly complications?
Disease control Recruiting nowThis study tests whether adding empagliflozin (a diabetes drug) to standard carvedilol treatment can prevent serious liver complications or death in people with cirrhosis and a stiff heart condition. About 400 adults aged 18–65 with cirrhosis and left ventricular diastolic dysfun…
Matched conditions: CIRRHOTIC CARDIOMYOPATHY
Phase: PHASE4 • Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh • Aim: Disease control
Last updated May 11, 2026 20:48 UTC
-
Heart scans could save lives in liver patients with sepsis
Knowledge-focused Recruiting nowThis study tests whether using a bedside heart ultrasound (POCUS) to guide fluid and medication decisions improves outcomes for 140 adults with liver cirrhosis and severe sepsis or septic shock. Participants will be randomly assigned to POCUS-guided care or standard guideline-bas…
Matched conditions: CIRRHOTIC CARDIOMYOPATHY
Phase: NA • Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh • Aim: Knowledge-focused
Last updated May 17, 2026 11:45 UTC